1. Home
  2. ASRV vs MNOV Comparison

ASRV vs MNOV Comparison

Compare ASRV & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AmeriServ Financial Inc.

ASRV

AmeriServ Financial Inc.

HOLD

Current Price

$4.41

Market Cap

66.2M

Sector

Finance

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.33

Market Cap

67.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASRV
MNOV
Founded
1983
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.2M
67.9M
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
ASRV
MNOV
Price
$4.41
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
13.5K
53.5K
Earning Date
04-21-2026
05-14-2026
Dividend Yield
3.16%
N/A
EPS Growth
61.90
N/A
EPS
0.11
N/A
Revenue
$14,634,000.00
$2,360,807.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$180.00
P/E Ratio
$38.09
N/A
Revenue Growth
N/A
194.15
52 Week Low
$2.64
$1.17
52 Week High
$4.49
$1.96

Technical Indicators

Market Signals
Indicator
ASRV
MNOV
Relative Strength Index (RSI) 69.72 44.92
Support Level $3.62 $1.30
Resistance Level N/A $1.52
Average True Range (ATR) 0.15 0.04
MACD 0.05 -0.01
Stochastic Oscillator 78.08 25.00

Price Performance

Historical Comparison
ASRV
MNOV

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: